Glomerular Filtration Rate (GFR) Calculator

Estimate kidney filtration with CKD-EPI, MDRD, Cockcroft-Gault, and cystatin C equations. Includes CKD stage context, albuminuria, and equation comparison for medication review or referral discussions.

⚠️ Reference Note: eGFR equations have limitations in extremes of body size, muscle mass, diet, and certain populations. This page is best used for equation comparison and staging context, not as a stand-alone dosing, nephrology-referral, or renal-replacement worksheet.
Presets:
mg/dL
years
kg
cm
Advanced: Cystatin C, ACR, BUN
mg/L
mg/g
mg/dL
g/dL
Planning notes, formulas, and examples

About the Glomerular Filtration Rate (GFR) Calculator

The Glomerular Filtration Rate (GFR) Calculator estimates kidney filtration with four commonly used equations: CKD-EPI, MDRD, Cockcroft-Gault, and CKD-EPI cystatin C. eGFR is widely used for CKD staging and medication review, but it remains an estimate rather than a direct measurement of filtration.

The CKD-EPI creatinine equation revision used on this page removed the race coefficient used in earlier versions after National Kidney Foundation (NKF) and American Society of Nephrology (ASN) Task Force recommendations. It is widely used for adult creatinine-based eGFR reporting.

This calculator can organize CKD stage, albuminuria category, and equation comparison in one place. Medication dosing, referral decisions, and CKD diagnosis should still be confirmed against guideline review, repeat testing, and the clinical context.

When This Page Helps

Equation choice can matter near staging and dosing thresholds, and side-by-side comparison can make those differences easier to see. The calculator is best used as a structured reference and discussion aid rather than a substitute for lab reporting, repeat measurements, or clinician judgment.

How to Use the Inputs

  1. Enter serum creatinine value and select the unit (mg/dL or µmol/L).
  2. Enter age and select sex for CKD-EPI and MDRD calculation.
  3. For Cockcroft-Gault, also enter body weight (and height for BSA-adjusted value).
  4. Optionally enter cystatin C, urine albumin-to-creatinine ratio, and BUN for additional analysis.
  5. Review CKD stage, risk category, drug dosing alerts, and equation comparison.
Formula used
CKD-EPI Race-Free Equation: eGFR = 142 × min(Scr/κ, 1)^α × max(Scr/κ, 1)^−1.200 × 0.9938^Age × [1.012 if female] Where: κ = 0.7 (F), 0.9 (M); α = −0.241 (F), −0.302 (M) MDRD: eGFR = 175 × Scr^−1.154 × Age^−0.203 × [0.742 if female] Cockcroft-Gault: CrCl = [(140 − Age) × Weight (kg) × (0.85 if female)] / (72 × Scr)

Example Calculation

Result: CKD-EPI: 38.9 mL/min/1.73m² — CKD Stage G3b

Using the CKD-EPI race-free equation with Scr 1.4 mg/dL in a 62-year-old female: κ=0.7, α=−0.241, Scr/κ = 2.0 (>1), so eGFR = 142 × 1^(−0.241) × 2.0^(−1.200) × 0.9938^62 × 1.012 = ~38.9. That falls in a range often labeled CKD G3b if the abnormality is persistent, but staging should be interpreted alongside repeat testing, albuminuria, medications, and whether acute kidney injury is present. The MDRD and Cockcroft-Gault results are shown for comparison because equation choice can change the number meaningfully near decision thresholds.

Tips & Best Practices

  • The CKD-EPI race-free equation is widely used for adult creatinine-based eGFR. MDRD is less accurate, especially when GFR >60.
  • Cockcroft-Gault is still required by some FDA drug labels — it estimates creatinine clearance (CrCl), not GFR, and is not BSA-indexed.
  • Creatinine is affected by muscle mass, meat intake, creatine supplements, and certain drugs (trimethoprim, cimetidine block tubular secretion and raise creatinine without changing GFR).
  • Confirm CKD with two eGFR measurements at least 90 days apart — a single low eGFR may reflect acute kidney injury, not CKD.
  • Cystatin C is useful when creatinine is unreliable: very muscular patients (creatinine overestimates GFR), amputees, or those with very low muscle mass (creatinine underestimates GFR).
  • An eGFR drop of >5 mL/min/year or >25% decline from baseline can suggest rapid progression and may prompt closer follow-up or nephrology review.

CKD-EPI vs. Earlier Equations

The CKD-EPI race-free equation revision used on this page was developed from a pooled dataset of 12 studies (N = 15,049) without using race as a variable. Compared with CKD-EPI 2009 without the race coefficient, the revised equation shows less bias and similar precision. For Black individuals, it generally produces slightly lower eGFR estimates than the 2009 equation with the race coefficient, which may lead to earlier CKD detection and referral. For non-Black individuals, results are very similar to CKD-EPI 2009. The MDRD equation, while historically important, systematically underestimates GFR above 60 mL/min and is no longer the preferred reporting equation in many settings.

Measured GFR

The gold standard for GFR measurement is clearance of an exogenous filtration marker: iohexol, iothalamate, inulin, or ⁵¹Cr-EDTA. Measured GFR (mGFR) involves IV injection of the marker and timed blood or urine sampling. It is expensive and time-consuming, so it is reserved for situations requiring high accuracy: kidney donor evaluation, clinical trials, monitoring nephrotoxic chemotherapy, confirming CKD in borderline cases, and patients where eGFR is unreliable.

Albuminuria and Cardiovascular Risk

Albuminuria is an independent kidney and cardiovascular risk marker, not just a CKD staging detail. The KDIGO risk matrix combines GFR and albuminuria categories to guide monitoring intensity and referral discussions. Medication choices such as renin-angiotensin system blockers or SGLT2 inhibitors depend on the broader diagnosis, lab pattern, and clinician review rather than eGFR alone.

Sources & Methodology

Last updated:

Methodology

This page calculates kidney-function estimates with the CKD-EPI creatinine equation used on this page, the MDRD equation, Cockcroft-Gault creatinine clearance, and an optional cystatin C equation when that value is entered. It then places the creatinine-based estimate beside CKD stage and albuminuria context so equation differences are easier to compare near staging or dosing thresholds.

These values are estimates, not measured filtration. Acute kidney injury, unstable creatinine, unusual muscle mass, amputations, pregnancy, and medication effects can all make the estimate less reliable than the displayed number suggests.

Sources

  • Recommendations for Implementing the CKD-EPI Race-Free eGFR Calculation (National Kidney Foundation / American Society of Nephrology Task Force) — Reference context for the race-free CKD-EPI transition.
  • KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (Kidney Disease: Improving Global Outcomes) — Guideline source for staging, albuminuria, and referral context.

Frequently Asked Questions

  • The CKD-EPI 2009 and MDRD equations included a race coefficient (multiplied eGFR by 1.159 for Black patients) based on the observation that Black individuals in the study cohort had higher average creatinine at the same measured GFR. However, this coefficient conflated race with biological characteristics, delayed CKD diagnosis in some Black patients, delayed referral and transplant listing, and perpetuated racial bias in clinical practice. NKF-ASN Task Force guidance recommended race-free equations, and the CKD-EPI revision removed race as a variable.